Compare Revvity Inc (RVTY) vs SOLAI Limited (SLAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs SOLAI Limited — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while SOLAI Limited trades at $3.72 (market cap $16.69M). The key difference: Revvity Inc is far larger — about 711.2× SOLAI Limited's market cap, and Revvity Inc pays a 0.26% dividend while SOLAI Limited pays none. Which is the better fit depends on your goals.
| RVTY | SLAI | |
|---|---|---|
Market Cap | $11.87B | $16.69M |
Sector | Technology | Technology |
52-Week High | $117.75 | $26.74 |
52-Week Low | $82.26 | $2.74 |
Enterprise Value | $14.36B | $16.33M |
Dividend Yield | 0.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About SOLAI Limited
SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →
